SCHEMBL248311

SCHEMBL248311

Fc1ccc2cc(CCNc3ncnc4[nH]cnc34)c(CCC3CC3)nc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 4/20 0.38
HTT P42858 5/20 0.32
PIK3CG P48736 4/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MAPK1 P28482 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 1/20 0.32
GFER P55789 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
JAK2 O60674 2/20 0.31
JAK1 P23458 1/20 0.31
AURKA O14965 1/20 0.31
DAPK3 O43293 1/20 0.31
PRKD3 O94806 1/20 0.31
PAK4 O96013 1/20 0.31
ABL1 P00519 1/20 0.31
LCK P06239 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249625 0.87 PIK3CD (0.35) MAP4K4HTTPIK3CGPIK3CDPIK3CA
SCHEMBL246483 0.87 MAP4K4 (0.38) MAP4K4HTTPIK3CGPIK3CDPIK3CA
SCHEMBL249677 0.85 PIK3CD (0.36) MAP4K4HTTPIK3CGPIK3CDPIK3CA
SCHEMBL249593 0.85 HTT (0.34) MAP4K4HTTPIK3CGPIK3CDPIK3CA
SCHEMBL250361 0.84 PIK3CD (0.38) MAP4K4HTTPIK3CGPIK3CDPIK3CA
SCHEMBL249789 0.84 MAP4K4 (0.35) MAP4K4HTTPIK3CGPIK3CDPIK3CA
SCHEMBL249910 0.84 PIK3CD (0.37) MAP4K4HTTPIK3CGPIK3CDPIK3CA
SCHEMBL248495 0.83 PIK3CD (0.38) MAP4K4HTTPIK3CGPIK3CDPIK3CA
SCHEMBL249334 0.83 IP6K1 (0.39) HTTPIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL248515 0.82 HTT (0.34) MAP4K4HTTPIK3CGPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588469-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003271-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed